Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $13

Benzinga Newsdesk www.benzinga.com Positive 54.8%

Neg 0% Neu 0% Pos 54.8%

Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $12 to $13.